MD4410C1 - Balanced infusion solution - Google Patents
Balanced infusion solutionInfo
- Publication number
- MD4410C1 MD4410C1 MDA20150042A MD20150042A MD4410C1 MD 4410 C1 MD4410 C1 MD 4410C1 MD A20150042 A MDA20150042 A MD A20150042A MD 20150042 A MD20150042 A MD 20150042A MD 4410 C1 MD4410 C1 MD 4410C1
- Authority
- MD
- Moldova
- Prior art keywords
- infusion solution
- balanced
- sodium
- balanced infusion
- intoxications
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine and pharmacology, namely to the saline infusion solutions having a detoxifying effect and can be used for treating diseases and conditions associated with organism intoxications of varying severity.Summary of the invention consists in that the balanced infusion solution comprises sodium, potassium and magnesium chlorides, sodium L-arginine succinate and water, in the following component ratio, mass %:
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014120144/15A RU2549448C1 (en) | 2014-05-20 | 2014-05-20 | Balanced infusion solution |
Publications (3)
Publication Number | Publication Date |
---|---|
MD20150042A2 MD20150042A2 (en) | 2015-12-31 |
MD4410B1 MD4410B1 (en) | 2016-04-30 |
MD4410C1 true MD4410C1 (en) | 2016-11-30 |
Family
ID=53289744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20150042A MD4410C1 (en) | 2014-05-20 | 2015-04-29 | Balanced infusion solution |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR099992A1 (en) |
EA (1) | EA024426B1 (en) |
MD (1) | MD4410C1 (en) |
NI (1) | NI201500056A (en) |
PE (1) | PE20151818A1 (en) |
RU (1) | RU2549448C1 (en) |
UA (1) | UA111116C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2676761C1 (en) * | 2017-10-09 | 2019-01-11 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Polyionic infusion solution |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA000879B1 (en) * | 1998-12-02 | 2000-06-26 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Infusion solution ''reamberin'' |
EA001099B1 (en) * | 1999-06-10 | 2000-10-30 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Injecting medical preparation "citoflavin" possessing cito-pretecting effect |
EA007865B1 (en) * | 2005-03-01 | 2007-02-27 | Общество С Ограниченной Ответственностью "Палисандр" | Disintoxicating infusion solution |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1395327A1 (en) * | 1981-03-05 | 1988-05-15 | Центральный научно-исследовательский институт гематологии и переливания крови | Infusion solution for correcting metabolic alkalosis "sorbamin" |
SU1630043A1 (en) * | 1984-06-01 | 1994-02-28 | Научно-исследовательский институт гематологии и переливания крови | Plasma-substituting solution "maфусoл" for antishock therapy |
RU2178296C1 (en) * | 2000-06-20 | 2002-01-20 | Государственный научный центр лекарственных средств | Infusion solution to treat cardiovascular system diseases |
RU2240116C1 (en) * | 2003-08-20 | 2004-11-20 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Disintoxicating infusion solution |
RU2006114834A (en) * | 2003-10-03 | 2007-11-20 | Оно Фармасьютикал Ко., Лтд. (Jp) | INFUSION DRUG CONTAINING (2R) -2-PROPYLOCTANIC ACID AS AN ACTIVE INGREDIENT |
-
2014
- 2014-05-20 RU RU2014120144/15A patent/RU2549448C1/en active IP Right Revival
- 2014-09-24 UA UAA201410465A patent/UA111116C2/en unknown
- 2014-11-21 EA EA201401164A patent/EA024426B1/en unknown
-
2015
- 2015-04-09 AR ARP150101069A patent/AR099992A1/en unknown
- 2015-04-17 NI NI201500056A patent/NI201500056A/en unknown
- 2015-04-21 PE PE2015000515A patent/PE20151818A1/en active IP Right Grant
- 2015-04-29 MD MDA20150042A patent/MD4410C1/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA000879B1 (en) * | 1998-12-02 | 2000-06-26 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Infusion solution ''reamberin'' |
EA001099B1 (en) * | 1999-06-10 | 2000-10-30 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Injecting medical preparation "citoflavin" possessing cito-pretecting effect |
EA007865B1 (en) * | 2005-03-01 | 2007-02-27 | Общество С Ограниченной Ответственностью "Палисандр" | Disintoxicating infusion solution |
Non-Patent Citations (2)
Title |
---|
EA 001099 B1 30.10.2000 * |
Реогемин. Регистрационное удостоверение Республики Беларусь РУ 12/12/2047 от 04.12.2012 * |
Also Published As
Publication number | Publication date |
---|---|
EA024426B1 (en) | 2016-09-30 |
AR099992A1 (en) | 2016-08-31 |
EA201401164A1 (en) | 2015-11-30 |
RU2549448C1 (en) | 2015-04-27 |
UA111116C2 (en) | 2016-03-25 |
MD4410B1 (en) | 2016-04-30 |
MD20150042A2 (en) | 2015-12-31 |
PE20151818A1 (en) | 2016-01-09 |
NI201500056A (en) | 2015-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD20170020A2 (en) | Compositions and methods of use for treating metabolic disorders | |
NZ738525A (en) | Cot modulators and methods of use thereof | |
MX2016015997A (en) | Preparation and use of crystalline beta-d-nicotinamide riboside. | |
JO3343B1 (en) | Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use | |
MX2021010460A (en) | Method of treatment with tradipitant. | |
MX2017011182A (en) | Amylin analogues. | |
MX364220B (en) | Methods of treating fibrosis. | |
WO2013022740A3 (en) | Gpr35 ligands and the uses thereof | |
PH12016502415A1 (en) | Treatment of severe hypertriglyceridemia | |
TN2015000255A1 (en) | Chitin or derivatives thereof for the prevention and/or treatment of parasitoses | |
MX2017012596A (en) | A pharmaceutical composition and the use thereof. | |
PH12017500747B1 (en) | Heterocyclic compound | |
EA201991175A1 (en) | THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS | |
MX2015008310A (en) | Method of treatment of hypoxia inducible factor (hif)-related conditions. | |
MY181685A (en) | Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer | |
MX2016000037A (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses. | |
PH12017500923A1 (en) | New dosage and use of a a2a antagonist | |
MD4410B1 (en) | Balanced infusion solution | |
MX2017009313A (en) | Intravenous baclofen formulations and treatment methods. | |
PH12017500084A1 (en) | Vitamin b2 and its use | |
IN2014MU01233A (en) | ||
MX2017003604A (en) | Dialysis solution. | |
MX2018011512A (en) | Use of insulin for promoting gastric emptying. | |
MX2018004656A (en) | Intravenous baclofen and methods of treatment. | |
TN2016000064A1 (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |